AbbVie Focuses On Humira’s Formulary Positioning Ahead Of Biosimilars

 
• By Joseph Haas
  
AbbVie exterior
AbbVie talked about US formulary positioning for Humira post-patent expiry • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business